Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.


Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013



All Upcoming Events
1 2 Next 
3D Cell Culture 201821 Feb 2018
3rd Annual Infection Control, Sterilization and Decontamination in Healthcare Congress21 Feb 2018
Infectious Diseases Diagnostics Conference21 Feb 2018
2nd Microbiome AgBioTech Summit 201826 Feb 2018
Pittcon Conference and Expo 201826 Feb 2018
Global Food Safety Conference 20185 Mar 2018
Superbugs and Superdrugs19 Mar 2018
Paediatric Clinical Trials 201819 Mar 2018
Bioprocessing Summit Europe20 Mar 2018
Drug Discovery 201821 Mar 2018
14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology9 Apr 2018
10th annual Adaptive Designs in Clinical Trials9 Apr 2018
analytica 201810 Apr 2018
Pre-Filled Syringes East Coast11 Apr 2018
AACR ANNUAL MEETING 201814 Apr 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)21 Apr 2018
CYTO 201828 Apr 2018
ICMSEM 2018: 20th International Conference on Materials Science, Engineering and Manufacturing3 May 2018
ASSET 201828 May 2018
66th ASMS Conference3 Jun 2018
ACHEMA 201811 Jun 2018
SLAS Europe 201827 Jun 2018
PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography8 Jul 2018
70th AACC Annual Scientific Meeting & Clinical Lab Expo29 Jul 2018
HPLC 201829 Jul 2018
Clinical Research 201810 Sep 2018
17th International Conference on Pathology8 Oct 2018
10th International Conference on Mass Spectrometry and Chromatography8 Oct 2018
3rd World Summit & Expo on Food Technology and Probiotics25 Oct 2018
3rd World Summit & Expo on Food Technology and Probiotics25 Oct 2018

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement